Table 4.
PET, V B | MRI | Relative difference (%), V B | p, V B | |
ESVs, mL | 96 ± 36 | 90 ± 29 | 8.5 ± 29.8 | 0.347 |
EDVs, mL | 206 ± 60 | 243 ± 65 | − 14.4 ± 18.4 | 0.012 |
SVs, mL | 110 ± 27 | 154 ± 42 | − 26.7 ± 15.1 | < 0.001 |
LVEFs, % | 55 ± 6 | 63 ± 6 | − 13.8 ± 8.7 | < 0.001 |
ESVv, mL | 87 ± 36 | 90 ± 29 | − 2.7 ± 26.8 | 0.622 |
EDVv, mL | 250 ± 69 | 244 ± 65 | 4.0 ± 21.6 | 0.652 |
SVv, mL | 163 ± 41 | 154 ± 42 | 8.1 ± 23.5 | 0.372 |
LVEFv, % | 66 ± 8 | 63 ± 6 | 4.2 ± 9.4 | 0.10 |
LVEFc, % | 75 ± 8 | 63 ± 6 | 17.8 ± 10 | < 0.001 |
PET, FP | MRI | Relative difference (%), FP | p, FP | |
ESVs, mL | 100 ± 38 | 90 ± 29 | 11.2 ± 19.5 | 0.041 |
EDVs, mL | 192 ± 59 | 243 ± 65 | − 21.2 ± 12.7 | < 0.001 |
SVs, mL | 93 ± 28 | 154 ± 42 | − 39.2 ± 13.6 | < 0.001 |
LVEFs, % | 49 ± 7 | 63 ± 6 | − 23.0 ± 8.9 | < 0.001 |
ESVv, mL | 99 ± 43 | 90 ± 29 | 9.2 ± 22.5 | 0.126 |
EDVv, mL | 235 ± 68 | 244 ± 65 | − 3.5 ± 14.7 | 0.320 |
SVv, mL | 136 ± 40 | 154 ± 42 | − 10.9 ± 19.8 | 0.031 |
LVEFv, % | 59 ± 9 | 63 ± 6 | − 7.8 ± 11.4 | 0.017 |
LVEFc, % | 69 ± 10 | 63 ± 6 | 8.6 ± 11.5 | 0.008 |